CPDALY < GNP per head COST EFFECTIVE
Download
Report
Transcript CPDALY < GNP per head COST EFFECTIVE
WHAT IS HEALTH
ECONOMICS?
ACCOUNTANTS CARE ONLY ABOUT
$$$$$$$$$$
PHYSICIANS CARE ONLY ABOUT
PATIENTS……
HEALTH ECONOMISTS CARE ABOUT
RESOURCE$ AND PATIENTS
ECONOMICS IS HOW TO ALLOCATE
SCARCE RESOURCES
COST-EFFECTIVENESS
ANALYSIS (CEA)
SAME GOAL
A
5
B
10
C
4
The cheapest method of attaining
the SAME GOAL
is the most cost-effective.
CHRONIC RENAL
DISEASE (Klareman)
HOSP DIALYSIS ($104,000)
9 years gained. CPLY=$11,600
HOME DIALYSIS ($38,000)
9 years gained. CPLY=$4,200
TRANSPLANT ($44,500)
17 years gained CPLY=$2,600
BURDEN
Process I
1.
Literature
search
Analysis,
review
2.
Epi
parameters
3.
Country
data
4.
Burden
Estimates
BURDEN
SCENARIOS
Fig 2: Projected Hepatitis A Cases with and without Vaccination
Program in Kazakhstan 2002-2041
40,000
Cases
30,000
20,000
10,000
0
2002
2006
2010
2014
2018
2022
2026
2030
2034
2038
BURDEN
PROGRAM
COSTS
SCENARIOS
BURDEN
VACCINE
PROGRAM
COSTS
SCENARIOS
DISEASE
TREATMENT
COSTS
Utilisation Rates for: self-care, self
care +medication/herbs, traditional
healer, community clinic/GP, inhospital care, intensive care, outpatient visits.
X
DISEASE
TREATMENT
COSTS
Unit Costs, including Laboratory tests,
Pharmaceuticals and Medications.
+
COSTS OF DISEASE SEQUELLAE
NET COST PER DALY
Net Cost = Cost of Intervention less
Averted Treatment Costs
DALYS = sum of life years saved
due to decreased mortality + life
years saved due to decreased
morbidity + reduction in
caregiver burden
DALY LOSS PER FRACTURE
Morbidity
Mortality
Hip
Vertebral
Proximal-humerus
Distal-radius
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
NET COST
DALY
PER: LIFE YEAR GAINED
LIFE SAVED
CASE-PREVENTED
COST-UTILITY ANALYSIS
COST SAVING
IF savings in treatment costs
> program costs
then we can reduce mobidity and
mortality AT NO NET COST
STRONG PSYCHOLOGICAL PUSH
FOR PROGRAMME
VERY COST EFFECTIVE
Project
considered
acceptable in relation to
resources available in
individual countries
CPDALY < GNP per head
COST EFFECTIVE
Project
considered
acceptable in relation to
resources available in
individual countries
CPDALY < 3 x GNP per head
ALBANIA has $1,120 GNP per
Head, CPDALY for HIB=$347
CPDALY < 3 x GNP per
head
VERY cost-effective if
WHO report, says project is
cost-effective if
CPDALY < GNP per head
Disease Clubs
Many donors adopt specific
diseases, creating jobs and
disease clubs, who advocate
using burden data, but avoid
true comparisons of
interventions using CEA.
BURDEN:Deaths
100
80
60
40
20
0
A
B
C
D
E
BURDEN:Life Years Lost
Disease B occurs at younger age
5000
4000
3000
2000
1000
0
A
B
C
D
E
BURDEN: DALY
Dis. C has high morbidity & sequelae
6000
4000
2000
0
A
B
C
D
E
SCENARIO: Potential DALYS SAVED
Disease D has high intervention efficacy
5000
4000
3000
2000
1000
0
A
B
C
D
E
$40
CUA: Cost per DALY:
Disease E has low intervention cost
$30
$20
$10
$0
A
B
C
D
E
3,500 additional DEATHS PREVENTED with
$10m budget
9000
6000
3000
0
A
E
250,000 extra DALYS SAVED WITH $10m
BUDGET
600000
400000
200000
0
A
E
INFECTIOUS
Good
efficacy
data, short
length of
trials
Hard to
model herd
immunity
NCD
Poor
efficacy
data due to
long term
needed for
results
(statins,
latency period)
Prevention Programmes
Eg:
smoking cessation or dietary
control
Very little population based
efficacy data as trials usually were
on specific populations such as
persons employed in factory etc.
GCEA: THREE
PROGRAMME EXAMPLE
A = Operation on rare disease
(Cost = $1m, QALYS saved = 1)
B = Operation and drug
treatment for rare disease (Cost =
$1,001,000, QALYS saved = 2)
C = Preventive Nutritonal
Campaign (Cost = $1,001,000,
QALYS= 500)
$
1m
A
B
C
A to B, get 1 QALY for
$1000 CPQALY = $,1000
0
1
2
QUALYS
Cost =
$ 1,001,000
QALY=500
CPQALY=
$2,000
500
INCREMENTAL CEA
CHOOSE
B SINCE CPQALY
= $1,000 cf
$2000 for nutrition
programme
$
1m
CPQ=$1,000,000
A
B
C
CPQ= $500,500
CPQ=2,000
0
1
2
QUALYS
500
GENERALISED CEA
CALCULATE NULL SETTING WHERE
NO INTERVENTION OCCURS
CALCULATE ALL INTERVENTIONS
WITH RESPECT TO NULL
CHOOSE INTERVENTION C AND
GAIN
2000-2 = 1998 QALYS
COST per QALY ($)
Low er CHOL
by drugs
22640
Breast Ca
Screening
9248
Kidney
Transplant
7536
Hip
replacement
GP smoking
cessation
1888
432
Low er CHOL 352
by diet
0
5
10
15
Thousands
20
25
CEA or CUA
TRANSPARENT, MORE
DEMOCRATIC METHOD OF
CHOOSING PROGRAMMES THAN
BY MARKET, PRESSURE GROUPS,
DONOR GROUPS ETC.
BIASED AGAINST ELDERLY AND
HANDICAPPED!
MORE EFFICIENT METHOD IN
TERMS OF MAXIMISING HEALTH
OUTPUT (DALYS- reflecting
mortality and morbidity gains)
HEALTH ECONOMICS
WITHOUT
HEALTH ECONOMICS
THANK YOU
………...….…..opportunity
cost